DDD investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and ...

NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. T ...

NEW YORK, July 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. WHAT'S NEXT? If you suffered a loss in 3D Systems Corporation during the relevant time frame, you have until August 12, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class memb ...

Core Viewpoint - 3D Systems has launched its NextDent Jetted Denture Solution, a first-to-market product that offers a faster, cost-effective, and scalable alternative to traditional denture fabrication, enhancing patient experience and providing a strong return on investment for dental labs [1][6][7]. Product Overview - The NextDent Jetted Denture Solution utilizes multiple materials in a single printing process to create durable, aesthetically pleasing monolithic dentures [1][6]. - The solution is based on the NextDent 300 MultiJet 3D printer, which allows for rapid production of patient-specific dentures without the need for post-curing steps [2][3]. - Two specialized FDA-cleared materials, NextDentJet Teeth and NextDent Jet Base, are used to ensure tooth rigidity and gum support while providing excellent aesthetics and toughness [2][3]. Manufacturing Efficiency - The continuous flow print process enables the production of single-piece dentures with significantly reduced lead times and labor costs, achieving production speeds that are up to 300% faster than traditional methods [3][4][9]. - The digital workflow can produce a final product in one day, compared to a five-day turnaround with traditional production methods [4][9]. Market Potential - The U.S. dental market for replacement products is projected to reach $600 million by 2029, with the overall U.S. dental market representing nearly $1 billion when combined with other segments [7][9]. - 3D Systems' NextDent Jetted Denture Solution is positioned as a key component of the company's strategy to address various facets of dentistry, including straightening, protecting, repairing, and replacing teeth [7][9]. Customer Feedback - Beta testing with leading dental labs has yielded positive feedback, highlighting the solution's ease of use, material properties, and efficiency improvements [4][9]. - Customers report significant reductions in fabrication time and labor costs, as well as enhanced patient experiences due to faster service and high-quality materials [9].

Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made misleading statements regarding its financial health and the impact of customer spending on its business [3][4]. Financial Performance - 3D Systems reported a Q4 non-GAAP loss of $0.19 per share, missing consensus estimates by $0.08 [6] - Q4 revenue was $111 million, representing a 3.4% year-over-year decline and falling short of expectations by $4.17 million [6] - Full-year revenue for 2024 was $440.1 million, a 10% decline year-over-year attributed to lower hardware sales and macroeconomic challenges [6] - The company experienced a $9 million revenue reduction in Q4 due to revised accounting estimates for its Regenerative Medicine Program [6] - In Q1 2025, revenue was $94.5 million, an 8% year-over-year decline, and below the consensus estimate of $99.5 million [6] - The net loss for Q1 2025 was $37 million (or $0.28 per share), more than double the $16 million loss in Q1 2024 [6] - An adjusted loss of $0.21 per share was reported, worse than the expected $0.14 loss [6] - The adjusted EBITDA was negative at $23.9 million, compared to a $20.1 million loss in Q1 2024 [6] Class Action Details - The class action lawsuit covers investors who purchased securities between August 13, 2024, and May 12, 2025 [1] - Investors have until August 12, 2025, to file a lead plaintiff motion [1] - The lawsuit claims that 3D Systems failed to disclose the negative impact of weakened customer spending and changes in its partnership with United Therapeutics Corporation [3]

Core Viewpoint - A class action securities lawsuit has been filed against 3D Systems Corporation, alleging securities fraud that negatively impacted investors between August 13, 2024, and May 12, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that 3D Systems Corporation understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [2]. - It is alleged that updated milestone criteria in the partnership with United Therapeutics Corporation would adversely affect the revenue from the Company's regenerative medicine program [2]. - As a result, the Company's public statements during the relevant period were materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 12, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require investors to serve as lead plaintiffs to share in any potential recovery, and there are no out-of-pocket costs or fees for class members [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Points - A shareholder class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made materially false and misleading statements regarding its business and operations [1] - The lawsuit claims that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [1] - Additionally, the updated milestone criteria in the United Partnership are said to negatively impact the revenue of the Company's Regenerative Medicine Program [1] Legal Information - Shareholders who purchased shares of 3D Systems between August 13, 2024, and May 12, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline to request to be appointed lead plaintiff in the case is August 12, 2025 [3] - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]

Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation and certain officers for alleged violations of federal securities laws during the Class Period from August 13, 2024, to May 12, 2025, seeking damages for misleading statements regarding the company's business and operations [1][8]. Company Overview - 3D Systems provides 3D printing and digital manufacturing solutions across various regions, earning revenue from two segments: Healthcare Solutions and Industrial Solutions [4]. - The Healthcare Solutions segment includes dental, medical devices, personalized health services, and regenerative medicine [4]. Regenerative Medicine Program - The Regenerative Medicine Program focuses on additive manufacturing for human organ transplantation, with a partnership with United Therapeutics Corporation aimed at developing 3D-printed lungs [5]. - Milestone criteria in the United Partnership are crucial for revenue recognition, and updates to these criteria affect the timing and probability of receiving milestone payments [6]. Financial Performance - The 3D printing industry has faced reduced customer spending, impacting sales; however, 3D Systems remains optimistic about future growth and has focused on gross margin expansion and operating expense improvements [7]. - For full-year 2025, the company projected revenue between $420 million and $435 million, indicating flat to modest growth, with a non-GAAP gross profit margin of 37% to 39% [7]. - In Q4 2024, 3D Systems reported a non-GAAP earnings-per-share of -$0.19 and sales revenue of $111 million, a 3.4% year-over-year decline [9]. - The company reported a full-year 2024 sales decrease of 10% to $440.1 million, attributed to lower hardware systems sales due to macroeconomic factors [9]. - In Q1 2025, revenue was $94.5 million, down 8% year-over-year, with a net loss of $37 million, more than doubling the loss from Q1 2024 [10]. Market Reaction - Following the announcement of disappointing financial results, 3D Systems' stock price fell significantly, closing at $2.15 per share on March 27, 2025, and further dropping to $1.87 per share on May 13, 2025 [9][11]. - Analysts expressed skepticism about the company's ability to achieve profitability in the near term, citing shrinking revenues and low investor interest in the sector [12].

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=157784&from=3 CLASS PERIOD: Aug ...

NEW YORK, July 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD).Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=157766&from=4CLASS PERIOD: August 13, ...